That's not a "new" theory 100% will be postponed; check our prior conversation history. If Amarin doesn't change final guidance...I believe that points to a very high end efficacy >40%.....(events in the placebo arm accelerate at the end of the trial if efficacy is high) I think the AHA and ACC see it the same and it's the reason why they posted "new" omega guidances.
Market Data 
Markets 
AI
